# A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World

> **NCT06728319** · — · ACTIVE_NOT_RECRUITING · sponsor: **Biodesix, Inc.** · enrollment: 4000 (estimated)

## Conditions studied

- Lung Nodules

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06728319
- **Lead sponsor:** Biodesix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-19
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06728319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06728319, "A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06728319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*